Home / Contributors / Andrew A. Nierenberg
Andrew A. Nierenberg

Andrew A. Nierenberg, M.D.

Dr. Nierenberg's research focuses on the treatment of affective disorders, including treatment-resistant depression, bipolar depression, and juvenile bipolar disorder. He has also explored the longitudinal course of affective disorders, management of antidepressant side effects, and pharmacoepidemiology. He is a member of the NIMH Initial Review Group for Intervention Research and has worked on NIMH contracts for the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) and Sequential Treatment Alternatives to Relieve Depression (STAR*D). Dr. Nierenberg is also the Principal Investigator for a three-site NIMH/NCCAM study of St. John's Wort for minor depression.

Positions

  • Associate Director, Depression Clinical and Research Program, Massachusetts General Hospital
  • Medical Director, Bipolar Research Program, Massachusetts General Hospital
  • Associate Professor of Psychiatry, Harvard Medical School

 

Education

  • M.D., Albert Einstein College of Medicine, Yeshiva University

 

Relevant Publications

  • Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007;356(17):1711-1722.
  • Iosifescu DV, Nierenberg AA. Preface. Psychiatr Clin North Am. 2007;30:xi-xiii.
  • Kobak KA, Kane JM, Thase ME, Nierenberg AA. Why do clinical trials fail? The problem of measurement error in clinical trials: Time to test new paradigms? J Clin Psychopharmacol. 2007;27:1-5.
  • Nierenberg AA, Katz J, Fava M. A critical overview of the pharmacologic management of treatment-resistant depression. Psychiatr Clin North Am. 2007;30:13-29.
  • Nierenberg AA, Trivedi MH, Fava M, et al. Family history of mood disorder and characteristics of major depressive disorder: A STAR*D (sequenced treatment alternatives to relieve depression) study. J Psychiatr Res. 2007;41:214-221.

 

Contributed Content